| Amazon Title | Mucinex Nightshift Cold & Flu Clear & Cool, Nighttime Multi-Symptom Relief, Pain Reliever, Fever Reducer, Cough Suppressant, Nasal Decongestant, Antihistamine, Menthol Flavor, 6 FL OZ |
|---|
| Bullet Features | - COLD & FLU RELIEF: Mucinex Nightshift Cold & Flu Clear & Cool helps reduce fever, relieve pain, headache, cough, runny nose, sneezing and sore throat, nasal congestion
- COOLING BURST OF MENTHOL: Instant burst of cooling Menthol flavor
- #1 TRUSTED COLD & COUGH BRAND: Mucinex is the #1 Cold and Cough brand doctors trust* and #1 Pharmacist Recommended Brand†
- PAIN RELIEVER: Contains Acetaminophen which reduces fever and relieves minor aches and pains thereby relieving your sore throat pain
- COUGH SUPPRESSANT: Contains Dextromethorphan HBr that helps relieve cough
- NASAL DECONGESTANT: Contains Phenylephrine HCl that provides relief for nasal congestion, sinus congestion and pressure
- ANTIHISTAMINE: Contains Triprolidine HCl that alleviates sneezing, runny nose, itching of the nose and watery eyes
- USAGE: Use as directed; For ages 12+ years
|
|---|
| Product Description | Mucinex Nightshift Cold & Flu Clear & Cool is a Night time Multi-Symptom Relief medicine for your Cold & Flu Symptoms with an instant burst of cooling Menthol flavor. Mucinex Nightshift Cold & Flu Clear & Cool helps reduce fever, relieve pain, headache, cough, runny nose, sneezing and sore throat, nasal congestion. Mucinex is the #1 Cough & Cold Brand Doctors Trust* and #1 Pharmacist Recommended Brand†. This product contains 6 Fluid Ounces. Use as directed, for Adults and Children 12 years of age and over.
SYMPTOMS RELIEVED: Mucinex Nightshift Cold & Flu Clear & Cool helps reduce fever, relieve pain, headache, cough, runny nose, sneezing and sore throat, nasal congestion
ACTIVE INGREDIENTS: Contains Acetaminophen - pain reliever/fever reducer; Dextromethorphan HBr - cough suppressant; Phenylephrine HCI - nasal decongestant; Triprolidine HCl – Antihistamine to alleviate sneezing, runny and itchy nose and watery eyes
Take only as Directed.
*IQVIA using ProVoice Survey, December 2022
†U.S. News & World Report/Pharmacy Times 2023-2024 |
|---|
